Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_assertion type Assertion NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_head.
- NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_assertion description "[MET activation confers a selective advantage to neoplastic cells in tumor progression and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_provenance.
- NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_assertion evidence source_evidence_literature NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_provenance.
- NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_assertion SIO_000772 20868306 NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_provenance.
- NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_assertion wasDerivedFrom befree-2016 NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_provenance.
- NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_assertion wasGeneratedBy ECO_0000203 NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_provenance.